Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences

Long-term deprescription in chronic pain and opioid use disorder patients: Pharmacogenetic and sex differences

More than half of patients with opioid use disorder for chronic non-cancer pain (CNCP) reduced their dose through a progressive opioid withdrawal supported by a rotation to buprenorphine and/or tramadol. The aim of this research is to analyse the long-term effectiveness of opioid deprescription taki...

Full description

Saved in:
Bibliographic Details
Main Authors: Muriel Javier, Escorial Mónica, Margarit César, Barrachina Jordi, Carvajal Cristian, Morales Domingo, Peiró Ana M.
Format: Article
Language:English
Published: Sciendo 2023-06-01
Series:Acta Pharmaceutica
Subjects:
chronic pain
drug deprescription
opioid use disorder
long-term monitoring
pharmacogenetics
sex differences
Online Access:https://doi.org/10.2478/acph-2023-0018
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.2478/acph-2023-0018

Similar Items